ADMA Biologics, Inc. (ADMA)
8.12
+0.06
(+0.74%)
USD |
NASDAQ |
Jun 09, 16:00
8.12
0.00 (0.00%)
After-Hours: 17:37
ADMA Biologics SG&A Expense (Quarterly) : 27.80M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 43.52M |
| Inovio Pharmaceuticals, Inc. | 7.880M |
| Zenas BioPharma, Inc. | 16.91M |
| Marker Therapeutics, Inc. | 1.230M |
| Praxis Precision Medicines, Inc. | 27.87M |